HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lipoprotein-associated phospholipase A2 concentrations in plasma are associated with the extent of coronary artery disease and correlate to adipose tissue levels of marine n-3 fatty acids.

Abstract
Lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) is an emerging risk factor for cardiovascular disease. In the present study, plasma levels of Lp-PLA(2) were measured in patients (n=301) admitted to elective coronary angiography because of suspected coronary artery disease (CAD). In a multiple linear regression analysis, the degree of CAD (0-, 1-, 2- or 3-vessel disease) and plasma LDL cholesterol significantly correlated to Lp-PLA(2) levels. Also the content of the marine n-3 fatty acid, eicosapentaenoic acid (EPA) in adipose tissue, a measure of long-term intake of seafood independently and inversely (r=-0.18, p<0.01) correlated with plasma levels of Lp-PLA(2). The results support the view that Lp-PLA(2) may relate to CAD and that intake of marine n-3 fatty acids might reduce plasma Lp-PLA(2) suggesting another mechanism by which n-3 fatty acids could reduce the risk of cardiovascular disease.
AuthorsErik Berg Schmidt, Wolfgang Koenig, Natalie Khuseyinova, Jeppe Hagstrup Christensen
JournalAtherosclerosis (Atherosclerosis) Vol. 196 Issue 1 Pg. 420-424 (Jan 2008) ISSN: 1879-1484 [Electronic] Ireland
PMID17157859 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Fatty Acids, Omega-3
  • 1-Alkyl-2-acetylglycerophosphocholine Esterase
Topics
  • 1-Alkyl-2-acetylglycerophosphocholine Esterase (blood)
  • Adipose Tissue (chemistry)
  • Aged
  • Coronary Artery Disease (blood, physiopathology)
  • Denmark
  • Fatty Acids, Omega-3 (analysis)
  • Female
  • Humans
  • Linear Models
  • Male
  • Middle Aged
  • Risk Factors
  • Seafood

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: